The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasias
出版年份 2013 全文链接
标题
The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasias
作者
关键词
P-glycoprotein, MDR protein, Bortezomib, Elacridar, Co-culture
出版物
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 71, Issue 5, Pages 1357-1368
出版商
Springer Nature
发表日期
2013-04-15
DOI
10.1007/s00280-013-2136-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The role of tumour–stromal interactions in modifying drug response: challenges and opportunities
- (2013) Douglas W. McMillin et al. NATURE REVIEWS DRUG DISCOVERY
- Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications
- (2011) J. Jakubikova et al. BLOOD
- Future Directions of Next-Generation Novel Therapies, Combination Approaches, and the Development of Personalized Medicine in Myeloma
- (2011) Constantine S. Mitsiades et al. JOURNAL OF CLINICAL ONCOLOGY
- Microenvironmental Influence on Pre-Clinical Activity of Polo-Like Kinase Inhibition in Multiple Myeloma: Implications for Clinical Translation
- (2011) Douglas W. McMillin et al. PLoS One
- Increased ABCB1 Expression in TP-110-Resistant RPMI-8226 Cells
- (2010) Masatomi IIJIMA et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Proteasome inhibitor MG132 reverses multidrug resistance of gastric cancer through enhancing apoptosis and inhibiting P-gp
- (2010) Yafei Zhang et al. CANCER BIOLOGY & THERAPY
- Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
- (2010) Douglas W McMillin et al. NATURE MEDICINE
- Antimyeloma Activity of the Orally Bioavailable Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235
- (2009) D. W. McMillin et al. CANCER RESEARCH
- Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib
- (2009) M. G. Ooi et al. CLINICAL CANCER RESEARCH
- Bortezomib restores stroma-mediated APO2L/TRAIL apoptosis resistance in multiple myeloma
- (2009) Lia E. Perez et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The effects of proteasome inhibitor bortezomib on a P-gp positive leukemia cell line K562/A02
- (2009) S. LÜ et al. International Journal of Laboratory Hematology
- Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines
- (2009) D. M. Collins et al. INVESTIGATIONAL NEW DRUGS
- PI3K/Akt inhibition modulates multidrug resistance and activates NF-κB in murine lymphoma cell lines
- (2008) Mariana G. García et al. LEUKEMIA RESEARCH
- In vitro activity of bortezomib in cultures of patient tumour cells—potential utility in haematological malignancies
- (2008) Kristina Wiberg et al. MEDICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started